Attention Deficit and Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity that significantly impact an individual's functioning and daily life. People with ADHD may struggle to maintain attention on tasks, follow instructions, and organize activities, leading to difficulties in academic, work, and social settings. Additionally, individuals with ADHD may exhibit hyperactive and impulsive behaviors, such as fidgeting, excessive talking, interrupting others, and taking risks without considering consequences. ADHD symptoms often manifest in childhood and can persist into adolescence and adulthood, posing challenges across the lifespan.
Genetics play a significant role in predisposing individuals to ADHD, with studies indicating a strong familial link and genetic variations associated with the disorder. Environmental factors, such as prenatal exposure to toxins, maternal smoking during pregnancy, and early childhood trauma, may also contribute to the development of ADHD. Neurologically, ADHD is associated with abnormalities in brain structure and function, particularly in regions responsible for attention, impulse control, and executive functioning. Despite its challenges, ADHD can be effectively managed with a combination of interventions, including medication, behavioral therapy, educational support, and lifestyle modifications. Early identification and intervention are key to addressing ADHD symptoms and minimizing the impact of the disorder on an individual's life.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States